-
20 Agoosto 2025, Abbisko Therapeutics waxay ku dhawaaqday in Xarunta Qiimaynta Daroogada (CDE) ee Maamulka Badeecadaha Caafimaadka Qaranka ee Shiinaha (NlPA) ay ogolaatay codsiga lND ee ku saabsan baaritaanka afka ee Abbisko ee PD-1 inhibitor, ABSK043, oo ay weheliso Shanghai Alist Pharmaceuticals KRAS ...Akhriso wax dheeraad ah»
-
Dhawaan, daraasaddii Antengene ee Marxaladda I/II CLINCH ee ATG-022 (CLDN18.2 antibody-drug conjugate), oo ah bukaan da' ah oo qaba kansarka caloosha oo horumarsan kaasoo ku horumaray noocyo badan oo kiimoterabi ah, daaweynta difaaca jirka iyo daaweynta bartilmaameedsan inkastoo metastases ballaaran ay gaareen jawaab dhammaystiran (CR) ka dib markii...Akhriso wax dheeraad ah»
-
Agoosto 13, 2025, Pacific Time, bogga rasmiga ah ee Shirka Adduunka ee Kansarka Sambabka 2025 (WCLC) ayaa soo saaray qoraallo cilmi-baaris ah oo la soo xulay shirka sanadkan, Waxyaabaha ugu muhiimsan waxaa ka mid ah qoraalka la cusbooneysiiyay ee tijaabada caafimaad ee Wejiga 1aad ee ugu horreeya ee aadanaha ee HLX43, Henlius' PD-L1 ADC. A...Akhriso wax dheeraad ah»
-
Agoosto 7, Xarunta Qiimaynta Daawada (CDE) ee Maamulka Badeecadaha Caafimaadka Qaranka (NMPA) ayaa ku dhawaaqday in duritaanka PA3-17 la soo jeediyay si loogu daro magacaabista daaweynta degdegga ah, oo loogu talagalay daaweynta bukaanada qaangaarka ah ee qaba limfaanka ba'an ee unugyada T-cell ee soo noqnoqda/iska caabiya...Akhriso wax dheeraad ah»
-
Agoosto 11, Xarunta Qiimaynta Daawada (CDE) ee Maamulka Badeecadaha Caafimaadka Qaranka (NMPA) waxay muujisay in codsiga InxMed ee kiniiniyada IN10018 loo soo jeediyay magacaabista daaweynta horumarsan, oo loogu talagalay in lagu daro D-1553 si loogu daaweeyo KRA-da maxalliga ah ee horumarsan ama metastatic...Akhriso wax dheeraad ah»
-
Mudane X waa bukaan da'diisu tahay 40-meeyada oo laga helay cudurka 'acral melanoma'. Ka dib markii qalliin xagjir ah lagu sameeyay ka dib markii la ogaaday cudurka sanadkii 2015, xaaladdiisu way degganayd muddo sagaal sano ah. Nasiib darro, qiyaastii sanad ka hor, cudurkiisu wuxuu ku soo noqdey iyadoo uu ku dhacay labada sambabood. In kasta oo uu helay xanuun caloosha iyo miskaha ah...Akhriso wax dheeraad ah»
-
Luulyo 31, AstraZeneca iyo Merck & Co. waxay si wadajir ah ugu dhawaaqeen in daawada joojisa PARP ee Lynparza, oo ay weheliso Abiraterone iyo prednisolone, loo ansixiyay Shiinaha si loogu daaweeyo bukaanada qaangaarka ah ee qaba kansarka qanjirka 'prostate' ee u adkaysta castration-ka (mCRPC) kuwaas oo sita jeermiska ama waxyaabaha...Akhriso wax dheeraad ah»
-
Luulyo 31, 2025, ImmuneOnco Biopharmaceuticals waxay ku dhawaaqday xog horudhac ah oo ku saabsan badbaadada iyo waxtarka laga helay daraasadda furan ee IMM2510 ee calaamadda furan ee wejiga 2aad iyadoo lala kaashanayo kiimoterabiga bukaanada safka hore ee qaba kansarka sambabka unugyada yaryar ee horumarsan (NSCLC) ee laga sameeyay Shiinaha. Laga bilaabo Luulyo 1, 2025,...Akhriso wax dheeraad ah»
-
Luulyo 30, Maamulka Badeecadaha Caafimaadka Qaranka (NMPA) ayaa si rasmi ah u ansixiyay suuqgeynta HICARA ee daaweynta bukaanada qaangaarka ah ee qaba lymphoma-ka unugyada B ee soo noqnoqda ama aan firfircoonayn (r/r LBCL) kuwaas oo helay laba ama in ka badan oo ah daaweyn nidaamsan. Tan waxaa ka mid ah unugyada B ee waaweyn ee kala firdhisan ...Akhriso wax dheeraad ah»
-
Dhawaan, bukaan qaba kansarka ganaca oo horumarsan kaasoo ku guuldareystay dhowr nooc oo daaweyn hore ah ayaa gaaray hoos u dhac joogto ah oo burooyinka ah ka dib markii uu qaatay daaweynta unugyada CAR-T ee KD-496, iyadoo la xaqiijiyay in la sii daayay 180 maalmood ka dib daaweynta. Waqtigan xaadirka ah, wali waxaa jira tijaabooyin caafimaad oo badan oo ah...Akhriso wax dheeraad ah»
-
Luulyo 16, joornaalka caalamiga ah ee heerka sare ah ee Nature Medicine ayaa daabacay xog cilmi baaris ah oo ku saabsan SHR-A1904, oo ah isku-darka daawada antibody-ga (ADC) oo bartilmaameedsanaya claudin 18.2 (CLDN18.2), si loogu daaweeyo kansarka caloosha ee horumarsan ama kansarka isku-xirka caloosha iyo mindhicirka (GC/GEJC). Cilmi-baarayaashu waxay sameeyeen baaritaankii ugu horreeyay ee...Akhriso wax dheeraad ah»
-
Luulyo 17, 2025 - Innovent Biologics ayaa ku dhawaaqday in Nature Medicine ay daabacday natiijooyinka daraasadda caafimaad ee Wejiga 1aad ee IBI343, oo ah nooc cusub oo ka hortagga CLDN18.2 ADC ah, oo loogu talagalay daaweynta adenocarcinoma-ka qanjirka caloosha/gastroesophageal ee horumarsan (G/GEJ). Daabacaadda caalamiga ah ee hormuudka ka ah...Akhriso wax dheeraad ah»
Hay'ad caafimaad oo iskaashato ah oo ka tirsan Isbitaalka Kansarka ee Beijing